Clinical Trials Logo

Carpal Tunnel Syndrome clinical trials

View clinical trials related to Carpal Tunnel Syndrome.

Filter by:
  • Withdrawn  
  • Page 1 ·  Next »

NCT ID: NCT05263128 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Turkish Version of the Hand20 Questionnaire With Carpal Tunnel Syndrome

Start date: August 1, 2022
Phase:
Study type: Observational [Patient Registry]

The questionnaire will be investigated by administering the Hand-20 questionnaire and the Boston Carpal Tunnel Syndrome Questionnaire to patients with carpal tunnel syndrome, one week apart.

NCT ID: NCT04070924 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Surgical Dressings After Endoscopic Carpal Tunnel Release

Start date: March 2024
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is the most common compressive neuropathy in the upper extremity. While carpal tunnel release (CTR), both open (OCTR) and endoscopic (ECTR), is safe and effective, there are questions regarding the use of postoperative dressings after surgery. It is not currently known if dressing choices influence post-operative pain, function or patient satisfaction after ECTR. A less cumbersome dressing (bandaid) may allow patients to perform daily tasks with more ease after surgery. The purpose of this investigation is to compare postoperative pain scores and patient satisfaction after ECTR for patients treated with conventional post-operative bulky soft tissue dressings versus those treated with a bandaid after surgery. The hypothesis is that patients using a bandaid after surgery will have an easier time with functional tasks after surgery and that pain scores will not significantly differ between the two groups. Furthermore, this study aims to determine if there are differences in patient satisfaction, functional outcomes, complications, and unscheduled healthcare contact between these two groups. This will be a randomized, controlled investigation.

NCT ID: NCT04017390 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

The Effect of Theraworx Foam in Carpal Tunnel Syndrome

Start date: January 1, 2022
Phase: Phase 4
Study type: Interventional

Participation will be for approximately 21 days (3 study visits,1 week apart with allowance for scheduling conflicts). A topical (or placebo) foam alone or with a splint will be used. Demographic and symptom information will be obtained. At each visit 3 questionnaires (BCT, CTS-6, and DASH) will be completed and an ultrasound of the wrist (median nerve) will be done to document any change in symptoms and/or in the size of the nerve. Random assignment will be to one of 4 groups: foam or placebo with or without a night splint. We will provide instruction on how to apply the foam, whether or not and how to wear the splint, and return visits.

NCT ID: NCT03909373 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Validation of PSFS in Carpal Tunnel Syndrome

Start date: March 18, 2019
Phase:
Study type: Observational

Validation of the Patient Specific Functional Scale in patients with carpal tunnel syndrome

NCT ID: NCT03802422 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Vitamin B12 for Carpal Tunnel Syndrome

Start date: April 20, 2019
Phase: N/A
Study type: Interventional

Carpal tunnel syndrome (CTS) is the most common peripheral entrapment neuropathy with involving compression of the median nerve in the carpal tunnel. Rather than other progressive disease, CTS is characterized by remission and recurrence. The hydrodissection could decrease the entrapment of nerve to restore blood supply. In addition, the Vitamin B12 was considered to be beneficial for peripheral neuropathy and pain relief. The investigators design a randomized, double-blind, controlled trail to assess the effect after ultrasound-guided hydrodissection with Vitamin B12 in patients with CTS.

NCT ID: NCT03779958 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Alternatives to Hand Therapy for Hand Surgery Patients

Start date: January 12, 2019
Phase:
Study type: Observational

Patients will be asked to use a mobile phone app to conduct their hand therapy after having hand surgery.

NCT ID: NCT03671473 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

Comparison of Focused and Radial Extracorporeal Shock Wave for Carpal Tunnel Syndrome

Start date: January 1, 2019
Phase: N/A
Study type: Interventional

Extracorporeal shock wave is a novel treatment for peripheral nerve entrapment. This study was designed to compare the efficacy of focused and radial extracorporeal shock wave for carpal tunnel syndrome.

NCT ID: NCT02683343 Withdrawn - Clinical trials for Carpal Tunnel Syndrome

The Use of Ultrasound to Quantify Muscle Overlying the Carpal Tunnel

Start date: July 2016
Phase: N/A
Study type: Observational

Carpal tunnel syndrome (CTS) is a common condition that still lacks a reliable, objective screening test. Many anatomical aspects of the syndrome have been studied including the dimensions of the carpal tunnel and shape of the nerve within the tunnel. The investigators have observed varying amounts of muscle overlying the carpal tunnel in patients undergoing surgery for the condition. Assuming that this muscle may have a dynamic role in the development of the condition, the investigators attempted to quantify this muscle using ultrasound (US). The purpose of this study was to devise a technique to evaluate the amount of muscle overlying the carpal tunnel. The hypothesis is that patients with carpal tunnel syndrome will have significantly more muscle overlying the carpal tunnel than individuals without carpal tunnel syndrome.

NCT ID: NCT02666911 Withdrawn - Carpal Tunnel Clinical Trials

Assessing the Comparability of 2D and 4D Ultrasound Measurements

Start date: January 2018
Phase: N/A
Study type: Interventional

Investigators will recruit 20 healthy volunteers between the ages of 18 and 80, who have no history of carpal tunnel syndrome or wrist injury. Images will be captured twice, first with the 2D transducer and then with the 4D transducer and compared to images captured with the new 4D transducer, using the same movement data analysis protocols. Investigators will also assess the inter and intrarater reliability of the 4D transducer images, by using two different sonographers, both trained in the technique, measuring the same blinded images on separate occasions, at least two weeks apart. The overall goal of this project is to assess the reliability, or reproducibility, of measurements in normal subjects using a novel 4D ultrasonographic method to characterize the subsynovial connective tissue (SSCT) and detect motion between SSCT, median nerve and tendon motion for the evaluation and diagnosis of patients with disorders affecting the carpal tunnel, especially carpal tunnel syndrome (CTS).

NCT ID: NCT02198521 Withdrawn - Pain Clinical Trials

Staged Bilateral Carpal Tunnel Release: Which Side Hurts More?

Start date: July 2014
Phase: N/A
Study type: Observational [Patient Registry]

Title Staged Bilateral Carpal Tunnel Release: Which Side Hurts More? Primary null hypothesis Patients undergoing staged bilateral open Carpal Tunnel Release (CTR) have no difference in overall pain intensity of pain between sides. Secondary null hypotheses - There is no correlation in overall pain intensity after open CTR surgery and distal sensory latency, distal motor latency, electromyography (EMG), demographics, occupation, avocation, relevant comorbidities, dominance, left vs. right, Pain Self-Efficacy, Patient Reported Outcomes Measurement Information System (PROMIS) Upper Extremity or PROMIS depression when both surgeries are performed within 6 months. - There is no difference in satisfaction with treatment at the time of suture removal after the first and second open CTR surgery when both are performed within 6 months.. IRB: 2009-p-001-019 ClinicalTrials.gov: Not mandatory, (b/o observational) Authors: Drijkoningen, Braun, Ring Journal: To be discussed Design: Prospective cohort study Background Many hand surgeons note that patients undergoing staged bilateral open carpal tunnel release often experience more pain with the second side. The investigator felt this was an easily testable hypothesis worthy of study. Subjects Eligibility: Inclusion: - Age 18 or older - Idiopathic carpal tunnel syndrome - No prior surgery for carpal tunnel syndrome Exclude: - Pregnant women - Not fluent in English Response Variables: - 11-point ordinal measure of overall pain intensity during and after surgery measured at the time of suture removal. - 11-point ordinal measure of satisfaction with treatment - PROMIS upper extremity Explanatory Variables: - Distal Sensory Latency (DSL) - Distal Motor Latency (DML) - EMG changes - Demographics: age, sex, race, occupation, avocation - Time limit between two surgeries < 6 months - Relevant comorbidities: Trapeziometacarpal (TMC) arthrosis, ulnar neuropathy, trigger finger - Involved hand (Dominance, Side) - First side vs. second side surgery - PROMIS Pain Interference Computer Adaptive Testing (CAT) - Pain Self Efficacy Questionnaire (PSEQ-2) - PROMIS Depression Methods The investigator and study staff will invite all adult patients (age 18 and older) presenting to the Orthopaedic Hand and Upper Extremity Service Department at Massachusetts General Hospital (MGH) with bilateral carpal tunnel syndrome planning staged bilateral carpal tunnel release. Analysis Power analysis An a priori power analysis for matched pairs was performed. To detect the difference between two dependent means an effect size of 0.5 at alpha of 0.05 and 80% power, a total sample size of 34 patients is needed.As the investigator expects to have patients who will be lost to follow-up the investigators will count 10% extra, a total of 38 patients will be needed. Univariate analysis: Variables will be presented with frequencies and percentages for categorical variables and as mean with standard deviation or median with interquartile range for respectively normal or non-normal distributed continuous variables. Normality of continuous distributed variables will be tested a paired T-Test. Bivariate and multivariable analysis will be performed and subsequently all variables with a probability < 0.10 in bivariate analysis will be inserted in a backward, stepwise, multivariable linear regression analysis to assess their ability to explain variation in outcome. The 11 point Likert Pain scale score is considered significant when there is a difference of more than 1.4 points (2.8 SD*0.5 effect size)on a scale from 1-10.[9]